Introduction
Aging affects various signal transduction events in cells and tissues, which may lead to the general decline in stress resistance and/or the deteriorative function in aged animals (Guarente and Kenyon, 2000; Mori et al., 2003) . Although both the efficacy and specificity of these signaling events could be affected with aging, recent studies suggest that specific pathways are significantly affected by aging, and such signaling pathways in cellular metabolism seem to confirm the major mechanisms of determining organismal longevity (Finkel and Holbrook, 2000; Kenyon, 2001; Longo and Finch, 2003; Kenyon, 2010; Mori and Mori, 2011) .
The phosphotyrosine signal adapter Shc is of particular interest with respect to aging-related cellular signaling because it is involved in the initial steps of intracellular signaling following the activation of various receptor tyrosine kinases (RTKs) (for review, see Bonfini et al., 1996; Luzi et al., 2000; Ravichandran, 2001) , and yet at least one isoform of Shc, i.e. p66-Shc, is able to transmit a distinct signal using serine/threonine phosphorylation in response to oxidative stress, leading to cellular apoptosis (Migliaccio et al., 1999; Nemoto and Finkel, 2002 ; for reviews, see Mori et al., 2003; Purdom and Chen, 2003; Trinei et al., 2009 ). As an adapter or docking molecule, the members of the Shc family play important roles in cardiovascular development (Lai and Pawson, 2000; Cosentino et al., 2008) , neuronal activation by neurotrophins (Nakamura et al., 1996 (Nakamura et al., , 1998 Liu and Meakin, 2002) , oxidative stress-related redox response (Migliaccio et al., 1999; Nemoto and Finkel, 2002; Haga et al., 2010) , cardiovascular complications (Cosentino et al., 2008; Francia et al., 2009) , adiposity (Tomilov et al., 2011) , and many other signaling routes including the main signal pathway of the so-called Ras-MAPK pathway via direct interaction with Grb2 (for reviews see Bonfini et al., 1996; Ravichandran, 2001) . The fact that a mutant mouse deficient in p66-Shc lived longer than the wild-type, possibly due to increased tolerance against oxidative stress in the absence of p66-Shc (Migliaccio et al., 1999) , has shed light on the specific involvement of this signaling molecule in the mechanisms of longevity determination and aging (Purdom and Chen, 2003; Orsini et al., 2006; Trinei et al., 2009) .
While several studies have examined the signaling efficacy of Shc in aged tissues, particularly using fibroblasts, hepatocytes, muscular and neural tissues (Palmer et al., 1999; Hutter et al., 2000; Jiang et al., 2003; Pandolfi et al., 2005) , few attempts have Adapter Anti-aging Longevity Phosphotyrosine Signal transduction A B S T R A C T The phosphotyrosine signaling followed by various receptor activations conforms a unique signaling platform during metazoan evolution, and is crucial for animal development, maturation, and aging. Shc is the most versatile bipartite phosphotyrosine signal adaptor harboring phosphotrosine-biding (PTB) and Src-homology2 (SH2) domains. Among the Shc adaptor family members, p66-Shc is of potential interest in aging studies, since its deletion in mice resulted in a longer lifespan and/or higher quality of life in later stages of life. However, a few studies have examined the gene expression profiles of p66-Shc in aging tissues. Here, we quantified the expression levels of transcripts of Shc-related isoforms in the liver and brain of young adult, middle-aged, and aged rats, and found that p66-Shc gene expression is specifically up-regulated in the aged liver and brain. In the aged liver tissue, p66-Shc expression was also evident at the protein level, and accumulated in the soluble fraction of the aged tissue. These results indicate that p66-Shc is not only related to animal longevity but also affected during aging, and thus the repression of p66-Shc could become a potential target for an anti-aging strategy.
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been made to quantify the age-difference in the gene expression of p66-Shc and other Shc-related proteins such as neuronal Shc (NShc, also designated ShcC) and Sck (also ShcB). The latter two are Shc-related homologues derived from distinct genes on different chromosomes (Luzi et al., 2000; Kojima et al., 2001) , and are expressed preferentially in the nervous system (Nakamura et al., 1996 (Nakamura et al., , 1998 O'Bryan et al., 1996; Mori and Mori, 2011) . Therefore, we should determine the mRNA and protein levels of Shc-related genes in young and old animals using a real-time polymerase chain reaction (PCR) and Western blot analysis in order to clarify whether the gene expression of either Shc, N-Shc, Sck, or particularly p66-Shc is affected during aging.
Materials and methods

Animals
Male Fischer 344 rats were used throughout the study. The rats were grouped into young (6 month-old), middle-aged (12 monthold), and aged (24-26 month-old) animals. The rats were maintained at 23 AE 1 8C under artificial lighting for 12 h per day on a standard show diet (CLEA Japan Inc.) and tap water provided ad libitum in the animal facility. All experiments were performed in accordance with the guidelines for animal experiments of National Institute for Longevity Science (NILS) and/or Nagasaki University.
RNA analysis
Tissue RNA was extracted and cDNA was generated using reverse transcriptase as described previously (Nakamura et al., 1998; Kojima et al., 2001; Mori et al., 2002; Kontani et al., 2005) . To quantify mRNA levels in aged tissues, we employed a real-time PCR using a LightCycler (Roche Diagnostics). Specific primers used for the measurement of each transcript are as follows: Shc-S (sense strand),
0 . These probes were selected for their individual specificity in the amplification of complementary DNA (cDNA) of either total Shc, p66-Shc, Sck or N-Shc as shown in Fig. 1 . The real-time PCR was performed in a capillary containing a total volume of 20 ml in the presence of appropriate PCR primers and a cDNA template. A reaction without the cDNA template was used for background subtraction, and a reaction with cDNA derived from glycelaldehyde 3-phosphate dehydrogenase (G3PDH) was used for normalization of the mRNA levels of each sample.
Protein analysis
Rats were sacrificed and decapitated under deep anesthesia with diethylether. Following the decapitation, the brains (cerebral cortex and cerebellum) and livers were isolated and dissected on ice. Each dissected region was homogenized in the lysis buffer (50 mM Tris-HCl, pH8.0/150 mM NaCl/1.0%NP-40/0.5% sodium deoxycholate/0.1% SDS/0.5 mM PMSF/10 mM NaF/2 mM Na 3 VO 4 / 1Â protease inhibitor complete; Roche Diagnostics GmbH, Mannheim, Germany). Aliquot of this total homogenate was stored, and was further sub-fractionated by a conventional procedure for separation of post-nuclear supernatant (S1), membraneous pellet (P1), and remaining soluble (S2) fractions. Samples containing equal amounts of protein (10 mg eq.) of each fraction were mixed with 2Â sample buffer, heated for 1 min at 95 8C, and subjected to electrophoresis on 5-20% gradient PAGE, and then transferred onto polyvinylidene difluoride (PVDF) membranes (GE Healthcare). Membranes were blocked with 5% blocking agent (GE Healthcare) in 1Â Tris-buffered saline/Tween-20 buffer for 1 h at room temperature and were incubated with primary antibodies, e.g., anti-Shc antibody (1:1000; C-20, Santa Cruz Biotechnology or 1:1000; 2432S, Cell Signal Technology); anti-N-Shc/ShcC antibody (1:5000; 610643, BD Transduction Laboratories) for overnight at 4 8C. The membrane was also blotted for Na + K + ATPase subunit a-1 (a marker for the plasma membrane fraction) in order to evaluate the validity of cellular fractionation and/or for Grb2 (G16720, purchased from Transduction Laboratories), another signaling molecule, for normalization. The membranes were rinsed with Tris-buffered saline/Tween-20 and incubated with secondary antibodies (anti-rabbit IgG antibody, Amersham Pharmacia) for 1 h at room temperature. Signals were detected with ECL (Amersham Pharmacia) or ECL Plus (GE Healthcare) on X-ray films.
Statistical analysis
Data were expressed as the mean AE S.E. Significant differences among groups were assessed by analysis of variance (ANOVA) Fischer's PLSD test (p < 0.01) using StatView-J 4.02 as described previously (Mori et al., 2002; Kontani et al., 2005) .
Results
Comparing the relative mRNA levels of Shc, N-Shc and Sck in the three age groups, no significant difference was observed in the real-time PCR analyses ( Fig. 2A, C, and D) ; however, we noted significant increase in the p66-Shc gene transcript being found in the brain tissue of aged rats (Fig. 2B) . Although the Shc, N-Shc and Sck mRNA levels tended to decrease during aging, the mRNA level of p66-Shc revealed a gradual increase. Since N-Shc and Sck are more abundantly expressed in the adult brain than Shc and further, Fig. 1 . Schematic drawing of domain features of Shc and related isoforms. The Shc family contains two homologues, Sck/ShcB and N-Shc/ShcC, which are predominantly expressed in the nervous system. Sck has only one form, p69, but N-Shc has large (p68) and small (p52) isoforms. Shc retains a large (p66) and smaller (p52/p46) forms. p66-Shc releases a unique signal from the N-terminally located CH2 domain via serine phosphorylation (pS), whereas the other forms send signals through tyrosine phosphorylation (pY) at the CH1 domain, which is present between two phosphotyrosine-binding domains, PTB and SH2. Regions used for PCR-amplification are marked by thick horizontal bars with arrowheads, and the positions of primer sets (sense (S) and anti-sense (AS) oligo-nucleotides) for each amplification is indicated above the schematic structures. These areas were selected for less homology among the family members.
p66-Shc is a minor isoform of the Shc gene transcripts, it is possible that no significant difference was observed in abundant gene transcripts due to technical limits.
The upregulation of p66-Shc gene expression was also evident in the liver of aged rats even though total Shc messenger levels remained unchanged (Fig. 3A and B) . A relative increase of p66-Shc gene products over p52 and p46 isoforms in the liver of aged rats was also confirmed at the level of protein by Western blot analysis ( Fig. 3C and D) . Much of the p66-Shc protein seemed present in the soluble fraction (or cytoplasm) rather than in membranous compartments (Fig. 4) . These results demonstrate that p66-Shc gene transcription is upregulated relative to p52/46-Shc in both tissues during aging, and further suggest the accumulation of p66-Shc protein in the soluble fraction of liver, in particular, of the aged animals.
Discussion
Overall, our results indicate that there is an imbalance in the gene expression of Shc isoforms during aging, and the relative abundance of p66-Shc gene products may reflect cellular conditions in aged animals with limited growth and/or differentiation, and a greater defense against extrinsic and intrinsic stress. When we initiated this study, a similar study on the gene expression of Shc-related proteins during aging in the brain, spinal cord, and hind limb muscles of young and aged rats (BKI strain of Harlan Sprague-Dawley rats; female) was published (Jiang et al., 2003) . In their aging study, comparisons were made between young (2-3 month-old) vs. aged (30 month-old) female Sprague-Dawley rats. Interestingly, their data indicated that Shc/ShcA gene expression was upregulated in aged tissues; p46-Shc and p66-Shc were increased in the spinal cord and muscles, respectively, of aged animals. In contrast, Sck/ShcB mRNA expression tended to be downregulated, and the expression of N-Shc/ShcC was unaffected by age. While they performed Western blots for p46/p52 and p66 Shc protein isoforms using protein samples extracted from young and aged thoracic spinal cord tissues, the changes in the expression of these genes were not confirmed at the protein level; no significant upregulation of p66-Shc protein was observed. In our current investigation, however, a specific upregulation of the expression of the p66-Shc isoform was confirmed at both the mRNA and protein levels in the liver. Thus, age-related accumulation of p66-Shc may be evident in the liver tissue, while in the nervous system, where the expression of ShcA is limited (Mori and Mori, 2011) , accumulation of p66-Shc protein may be hardly detected in either spinal cord (Jiang et al., 2003) , cerebral cortex or cerebellum (this study).
Our current study may be viewed as a confirmatory study of the previous study by the Swedish group (Jiang et al., 2003) with minor differences in methods. While we examined male Fischer 344 rats, the Ulfhake's group utilized female Sprague-Dawley rats. There were also some differences in age groups; we compared 6-month vs. 24-26-month-old animals whereas they compared 2-3-month vs. 30-month-old animals. Yet both studies demonstrated selective upregulation of p66-Shc in the muscle, liver, spinal cord, and brain, at least at the mRNA level. As aforementioned, we further revealed that p66 Shc protein accumulated in the soluble fraction of the liver of aged animals. While the p66-Shc protein is claimed to serve as the radical generator in the mitochondrial inner membrane (Giorgio et al., 2005; Trinei et al., 2009) , there might be additional role(s) of p66-Shc in the cytoplasm, comparable to other short forms including p52 and p46. The major forms of Shc, i.e. p52 and p46, play an essential role in cellular growth and differentiation via the activation of the Ras-MAPK signaling route (Bonfini et al., 1996; Ravichandran, 2001 ), whereas p66-Shc, the minor component of Shc, functions negatively against this signaling pathway (Migliaccio et al., 1997) . Therefore, the relative increase in p66-Shc may be relevant to the reduced cell division and differentiation in tissues of aged animals. Alternatively, since p66-Shc is implicated in oxidative stress-activated signaling and cellular apoptosis in conditions of stress (Migliaccio et al., 1999; Giorgio et al., 2005) , the higher levels of p66-Shc may be responsible for the susceptibility of aged tissues to cellular deterioration including cell death following various stress-related insults during aging.
It is worth to note that p66-Shc is highly abundant in fibroblasts of centenarians (Pandolfi et al., 2005) . The abundance of p66-Shc in the liver of aged animals and centenarian fibroblasts per se might be merely the outcome of aging rather than the pre-requisite to acquire a superior longevity. Given that the p66-Shc gene-deficient mouse strain resulted in a longer lifespan (Migliaccio et al., 1999) , accumulation of p66-Shc should be considered non-beneficial or rather deteriorative to longevity. Thus, we assume that the upregulation of p66-Shc gene expression in the aged tissue and also in the centenarians' fibroblasts could be due to the outcome of accumulation during aging.
The accumulation of p66-Shc could thus be the outcome of aging. If so, p66-Shc in the aged tissue could be a potential target for anti-aging strategy. Accumulative evidence clearly indicates that the deletion and/or suppression of p66-Shc function should be beneficial for longer lifespan or higher QOL (Camici et al., 2011) . As we showed herein, the p66-Shc gene expression does increase, if not diminish, during aging, making it a reasonable target for antiaging therapy. Small molecular compounds that would selectively inhibit the phosphorylation of Ser36 at the CH2 domain of p66-Shc Fig. 3 . Quantification of total Shc and p66-Shc mRNA and protein levels in the liver of young (6 month-old, n = 6), middle-aged (12 month-old, n = 6), and old (26 month-old, n = 5) rats as determined by real time PCR and Western blotting. (A, B) Relative mRNA levels of total Shc and p66-Shc mRNAs. Values are relative to the levels of G3PDH mRNA in each tissue. The p66-Shc mRNA level was significantly higher in the liver of old rats young rats (p = 0.01). (C) Western blot analysis of p66-Shc and p52/46-Shc protein levels in the young (6 month-old, lanes 1-5) and old (26 month-old, lanes 6-10) rats using polyclonal anti-Shc antibody. For compariosn, the blot was re-probed with anti-Grb2 antibody, showing that the Grb2 level was relatively unchanged during aging. (D) Comparison of p52/46 Shc and p66-Shc protein levels in the young and old rat liver as determined by densitometry of the Western blot shown in panel C (n = 5 each). rats is shown (n = 3 each). Protein samples (10 mg) from each sample of total homogenate (total), or post-nuclear supernatant (S1), membranous pellet subfraction (P1), and 100,000 Â g supernatant (S2) from each tissue were resolved on 5-20% polyacrylamide gradient gel, and probed with anti-Shc (upper panel), anti-N-Shc (middle panel), and anti-sodium-potassium ATPase a-1 subunit (lower panel) antibodies. Note that p66-Shc is abundant in the soluble fractions (S1 and S2) of the aged liver. No difference was observed in the level of p68-N-Shc in the cerebral cortex between the young and old rats.
could be a candidate for therapeutic intervention in the very elderly population in developed countries.
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